News Sumitomo ups ante and wins support for Myovant takeover A sweetened offer from Sumitomo Pharma has convinced endocrinology specialist Myovant to agree to a takeover, after its first was rejected.
News Exscientia starts trials of AI-designed Alzheimer's drug Exscientia has advanced a drug candidate for Alzheimer's disease into human testing, the third clinical-stage project for the UK specialist in artificial intelligence (AI) based drug discov